ResMed out of San Diego, California won FDA clearance and is releasing its VPAP COPD device. A bilevel PAP (positive air pressure) device, it should help people with severe respiratory conditions breathe better at home and stay out of the hospital.
The device is used during sleep when assisted breathing is most needed. It applies rapid pressure during inhalation and allows for slow release of the exhaled breath, hopefully improving the lung’s own ability to exchange gas.
Built on the popular ResMed S9™ Series platform, the VPAP COPD device is compact and easy for a patient to integrate into a sleep setting. Combined with the companion H5i™ heated humidification device, the VPAP COPD creates a comfortable patient experience, increasing the likelihood of patients continuing their therapy.
As part of the total therapy solution, the VPAP COPD device may be wirelessly connected to ResMed’s secure, cloud-based EasyCare Online monitoring system. EasyCare Online allows physicians, hospitals and homecare partners to monitor patient use and patient respiratory health on a daily basis. This immediate and automated feedback is critical during the important 30-day post-discharge period, and can help reduce the time and labor hospitals invest in follow-up with these patients, while possibly achieving a better outcome.
ResMed has also created a special ClimateLine™ tubing between the humidifier and mask that has an oxygen line port next to the VPAP COPD device. Oxygen therapy can be easily combined with the VPAP COPD and its Climate Control humidification system.
Press release: ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatmen
